Can DNA-Guided dosing save lives? new study targets african americans

NCT ID NCT03225820

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving doctors genetic information about their African American patients can help them prescribe the blood thinner warfarin more safely and effectively. Researchers will track how often doctors use this genetic guidance and whether it leads to better health outcomes. The study involves 1,000 African American adults at multiple hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFORMATION SEEKING BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Information Seeking Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Northwestern University

    NOT_YET_RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-••••

  • The University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 60607, United States

    Contact Phone: •••-•••-••••